1 | countries | 10,633 |
2 | continents | 120 |
3 | economies | 63 |
4 | races/ethnicities | 15 |
5 | minnow | 10 |
6 | passerines | 9 |
7 | peritonei | 9 |
8 | countries/regions | 6 |
9 | kebele | 6 |
10 | minnows | 6 |
11 | dvt/pe | 5 |
12 | manitobans | 5 |
13 | zang-organs | 5 |
14 | artiodactyls | 4 |
15 | ruvb | 4 |
16 | speleoclimatotherapy | 4 |
17 | subgenera | 4 |
18 | airlines | 3 |
19 | bed-sores | 3 |
20 | bullhead | 3 |
21 | gyre | 3 |
22 | neolithization | 3 |
23 | proteinuria/pre-eclampsia | 3 |
24 | aeg-35156 | 2 |
25 | click-throughs | 2 |
26 | f3hs | 2 |
27 | fasidotril | 2 |
28 | gold-miners | 2 |
29 | mastigocoel | 2 |
30 | mbp-8298 | 2 |
31 | peptides/proteins | 2 |
32 | variables-age | 2 |
33 | world.carbamazepine | 2 |
34 | 2d-crystals | 1 |
35 | 3-/4-aminoacetophenones | 1 |
36 | 3-phenyl-1h-5-pyrazolylamine | 1 |
37 | 493/qaly | 1 |
38 | addisonian | 1 |
39 | all-types | 1 |
40 | amaoxs | 1 |
41 | amoxycillins | 1 |
42 | anti-ebna-igg | 1 |
43 | anti-ebv-iga | 1 |
44 | antypsychotics | 1 |
45 | avifaunas | 1 |
46 | becatecarin | 1 |
47 | biological-response-modifying | 1 |
48 | bos2-3 | 1 |
49 | brain.conclusion | 1 |
50 | broncodilators | 1 |
51 | cachexias | 1 |
52 | cells/tissues/organs | 1 |
53 | chitosan-egg | 1 |
54 | co-primaries | 1 |
55 | com-plications | 1 |
56 | compairsons | 1 |
57 | contingents | 1 |
58 | cormorbidities | 1 |
59 | countries-have | 1 |
60 | countries. | 1 |
61 | countries.3 | 1 |
62 | countries.however | 1 |
63 | countries.this | 1 |
64 | diet-mediated | 1 |
65 | district-13 | 1 |
66 | dlc-knees | 1 |
67 | double-blind/placebo-controlled | 1 |
68 | drugs/combinations | 1 |
69 | drugs/diseases | 1 |
70 | dysmenoorhea | 1 |
71 | e-seroconversion | 1 |
72 | embryo/foetus | 1 |
73 | endpoints.ais | 1 |
74 | environmentally-persistent | 1 |
75 | etc-588 | 1 |
76 | eugenol- | 1 |
77 | eunectics | 1 |
78 | extraperitonei | 1 |
79 | eye-tech-solutions | 1 |
80 | favild | 1 |
81 | feamales | 1 |
82 | food-allergic-children/carers | 1 |
83 | fungal- | 1 |
84 | gastropathies | 1 |
85 | glangeaud | 1 |
86 | gw-1000 | 1 |
87 | haemorrage | 1 |
88 | handcrafts | 1 |
89 | haplosclerids | 1 |
90 | hepex-c | 1 |
91 | holavax-typhoid | 1 |
92 | hormones/elicitors | 1 |
93 | hyaluronans/hylan | 1 |
94 | hyperglycemics | 1 |
95 | hypokelemia | 1 |
96 | influenza-like-symptoms | 1 |
97 | interferon-α-kinoid | 1 |
98 | kalyana | 1 |
99 | keratinopathies | 1 |
100 | logic-driven | 1 |
101 | lot-specific | 1 |
102 | mannosyltransferases | 1 |
103 | mantids | 1 |
104 | medicalresearchers | 1 |
105 | mega-studies | 1 |
106 | metakenkoh | 1 |
107 | metaproteins | 1 |
108 | methods.conclusions | 1 |
109 | mir-ref | 1 |
110 | mp29-02-patients | 1 |
111 | ncx-701 | 1 |
112 | noncardiovascular-related | 1 |
113 | nonhormonal-based | 1 |
114 | nonincisional | 1 |
115 | nonpolypoid | 1 |
116 | oligo-p-xylenes | 1 |
117 | omzs | 1 |
118 | onyvax-105 | 1 |
119 | ophidiidae | 1 |
120 | organometalloids | 1 |
121 | oryzomyini | 1 |
122 | parrotfishes | 1 |
123 | petecchiae | 1 |
124 | philometrids | 1 |
125 | pol32-dependent | 1 |
126 | policies/reports | 1 |
127 | preelampsia | 1 |
128 | pressure-lvdp | 1 |
129 | professionals-researchers | 1 |
130 | proposals:1 | 1 |
131 | pyelitis/pyelonephritis | 1 |
132 | pyocystitis | 1 |
133 | ravlts | 1 |
134 | rehabmaster™ | 1 |
135 | rejectors | 1 |
136 | reserachers | 1 |
137 | resons | 1 |
138 | right-face | 1 |
139 | self-tissue | 1 |
140 | settings.there | 1 |
141 | sgop | 1 |
142 | stone-quarries | 1 |
143 | studies/interventions | 1 |
144 | subgenogroups | 1 |
145 | subregistry | 1 |
146 | tachyarhythmias | 1 |
147 | tahsfs | 1 |
148 | thiolases | 1 |
149 | trpv1-dependent | 1 |
150 | velafermin | 1 |
151 | vres | 1 |
152 | weakly-polar | 1 |
153 | years.2 | 1 |
154 | yers | 1 |
155 | ≥2+imr | 1 |
1 | 2d-crystals | 1 |
2 | 3-/4-aminoacetophenones | 1 |
3 | 3-phenyl-1h-5-pyrazolylamine | 1 |
4 | 493/qaly | 1 |
5 | addisonian | 1 |
6 | aeg-35156 | 2 |
7 | airlines | 3 |
8 | all-types | 1 |
9 | amaoxs | 1 |
10 | amoxycillins | 1 |
11 | anti-ebna-igg | 1 |
12 | anti-ebv-iga | 1 |
13 | antypsychotics | 1 |
14 | artiodactyls | 4 |
15 | avifaunas | 1 |
16 | becatecarin | 1 |
17 | bed-sores | 3 |
18 | biological-response-modifying | 1 |
19 | bos2-3 | 1 |
20 | brain.conclusion | 1 |
21 | broncodilators | 1 |
22 | bullhead | 3 |
23 | cachexias | 1 |
24 | cells/tissues/organs | 1 |
25 | chitosan-egg | 1 |
26 | click-throughs | 2 |
27 | co-primaries | 1 |
28 | com-plications | 1 |
29 | compairsons | 1 |
30 | continents | 120 |
31 | contingents | 1 |
32 | cormorbidities | 1 |
33 | countries | 10,633 |
34 | countries-have | 1 |
35 | countries. | 1 |
36 | countries.3 | 1 |
37 | countries.however | 1 |
38 | countries.this | 1 |
39 | countries/regions | 6 |
40 | diet-mediated | 1 |
41 | district-13 | 1 |
42 | dlc-knees | 1 |
43 | double-blind/placebo-controlled | 1 |
44 | drugs/combinations | 1 |
45 | drugs/diseases | 1 |
46 | dvt/pe | 5 |
47 | dysmenoorhea | 1 |
48 | e-seroconversion | 1 |
49 | economies | 63 |
50 | embryo/foetus | 1 |
51 | endpoints.ais | 1 |
52 | environmentally-persistent | 1 |
53 | etc-588 | 1 |
54 | eugenol- | 1 |
55 | eunectics | 1 |
56 | extraperitonei | 1 |
57 | eye-tech-solutions | 1 |
58 | f3hs | 2 |
59 | fasidotril | 2 |
60 | favild | 1 |
61 | feamales | 1 |
62 | food-allergic-children/carers | 1 |
63 | fungal- | 1 |
64 | gastropathies | 1 |
65 | glangeaud | 1 |
66 | gold-miners | 2 |
67 | gw-1000 | 1 |
68 | gyre | 3 |
69 | haemorrage | 1 |
70 | handcrafts | 1 |
71 | haplosclerids | 1 |
72 | hepex-c | 1 |
73 | holavax-typhoid | 1 |
74 | hormones/elicitors | 1 |
75 | hyaluronans/hylan | 1 |
76 | hyperglycemics | 1 |
77 | hypokelemia | 1 |
78 | influenza-like-symptoms | 1 |
79 | interferon-α-kinoid | 1 |
80 | kalyana | 1 |
81 | kebele | 6 |
82 | keratinopathies | 1 |
83 | logic-driven | 1 |
84 | lot-specific | 1 |
85 | manitobans | 5 |
86 | mannosyltransferases | 1 |
87 | mantids | 1 |
88 | mastigocoel | 2 |
89 | mbp-8298 | 2 |
90 | medicalresearchers | 1 |
91 | mega-studies | 1 |
92 | metakenkoh | 1 |
93 | metaproteins | 1 |
94 | methods.conclusions | 1 |
95 | minnow | 10 |
96 | minnows | 6 |
97 | mir-ref | 1 |
98 | mp29-02-patients | 1 |
99 | ncx-701 | 1 |
100 | neolithization | 3 |
101 | noncardiovascular-related | 1 |
102 | nonhormonal-based | 1 |
103 | nonincisional | 1 |
104 | nonpolypoid | 1 |
105 | oligo-p-xylenes | 1 |
106 | omzs | 1 |
107 | onyvax-105 | 1 |
108 | ophidiidae | 1 |
109 | organometalloids | 1 |
110 | oryzomyini | 1 |
111 | parrotfishes | 1 |
112 | passerines | 9 |
113 | peptides/proteins | 2 |
114 | peritonei | 9 |
115 | petecchiae | 1 |
116 | philometrids | 1 |
117 | pol32-dependent | 1 |
118 | policies/reports | 1 |
119 | preelampsia | 1 |
120 | pressure-lvdp | 1 |
121 | professionals-researchers | 1 |
122 | proposals:1 | 1 |
123 | proteinuria/pre-eclampsia | 3 |
124 | pyelitis/pyelonephritis | 1 |
125 | pyocystitis | 1 |
126 | races/ethnicities | 15 |
127 | ravlts | 1 |
128 | rehabmaster™ | 1 |
129 | rejectors | 1 |
130 | reserachers | 1 |
131 | resons | 1 |
132 | right-face | 1 |
133 | ruvb | 4 |
134 | self-tissue | 1 |
135 | settings.there | 1 |
136 | sgop | 1 |
137 | speleoclimatotherapy | 4 |
138 | stone-quarries | 1 |
139 | studies/interventions | 1 |
140 | subgenera | 4 |
141 | subgenogroups | 1 |
142 | subregistry | 1 |
143 | tachyarhythmias | 1 |
144 | tahsfs | 1 |
145 | thiolases | 1 |
146 | trpv1-dependent | 1 |
147 | variables-age | 2 |
148 | velafermin | 1 |
149 | vres | 1 |
150 | weakly-polar | 1 |
151 | world.carbamazepine | 2 |
152 | years.2 | 1 |
153 | yers | 1 |
154 | zang-organs | 5 |
155 | ≥2+imr | 1 |
1 | fungal- | 1 |
2 | eugenol- | 1 |
3 | countries. | 1 |
4 | gw-1000 | 1 |
5 | ncx-701 | 1 |
6 | proposals:1 | 1 |
7 | years.2 | 1 |
8 | bos2-3 | 1 |
9 | countries.3 | 1 |
10 | district-13 | 1 |
11 | onyvax-105 | 1 |
12 | aeg-35156 | 2 |
13 | etc-588 | 1 |
14 | mbp-8298 | 2 |
15 | dysmenoorhea | 1 |
16 | anti-ebv-iga | 1 |
17 | hypokelemia | 1 |
18 | proteinuria/pre-eclampsia | 3 |
19 | preelampsia | 1 |
20 | kalyana | 1 |
21 | subgenera | 4 |
22 | ruvb | 4 |
23 | hepex-c | 1 |
24 | lot-specific | 1 |
25 | bullhead | 3 |
26 | double-blind/placebo-controlled | 1 |
27 | nonhormonal-based | 1 |
28 | diet-mediated | 1 |
29 | noncardiovascular-related | 1 |
30 | holavax-typhoid | 1 |
31 | interferon-α-kinoid | 1 |
32 | nonpolypoid | 1 |
33 | favild | 1 |
34 | glangeaud | 1 |
35 | ophidiidae | 1 |
36 | petecchiae | 1 |
37 | right-face | 1 |
38 | variables-age | 2 |
39 | haemorrage | 1 |
40 | kebele | 6 |
41 | 3-phenyl-1h-5-pyrazolylamine | 1 |
42 | world.carbamazepine | 2 |
43 | dvt/pe | 5 |
44 | settings.there | 1 |
45 | gyre | 3 |
46 | self-tissue | 1 |
47 | countries-have | 1 |
48 | mir-ref | 1 |
49 | chitosan-egg | 1 |
50 | anti-ebna-igg | 1 |
51 | biological-response-modifying | 1 |
52 | metakenkoh | 1 |
53 | peritonei | 9 |
54 | extraperitonei | 1 |
55 | oryzomyini | 1 |
56 | nonincisional | 1 |
57 | mastigocoel | 2 |
58 | fasidotril | 2 |
59 | addisonian | 1 |
60 | hyaluronans/hylan | 1 |
61 | logic-driven | 1 |
62 | velafermin | 1 |
63 | becatecarin | 1 |
64 | e-seroconversion | 1 |
65 | brain.conclusion | 1 |
66 | neolithization | 3 |
67 | pressure-lvdp | 1 |
68 | sgop | 1 |
69 | weakly-polar | 1 |
70 | countries.however | 1 |
71 | ≥2+imr | 1 |
72 | tachyarhythmias | 1 |
73 | cachexias | 1 |
74 | avifaunas | 1 |
75 | hyperglycemics | 1 |
76 | eunectics | 1 |
77 | antypsychotics | 1 |
78 | organometalloids | 1 |
79 | haplosclerids | 1 |
80 | philometrids | 1 |
81 | mantids | 1 |
82 | dlc-knees | 1 |
83 | parrotfishes | 1 |
84 | mega-studies | 1 |
85 | keratinopathies | 1 |
86 | gastropathies | 1 |
87 | economies | 63 |
88 | co-primaries | 1 |
89 | stone-quarries | 1 |
90 | countries | 10,633 |
91 | races/ethnicities | 15 |
92 | cormorbidities | 1 |
93 | feamales | 1 |
94 | oligo-p-xylenes | 1 |
95 | airlines | 3 |
96 | passerines | 9 |
97 | 3-/4-aminoacetophenones | 1 |
98 | all-types | 1 |
99 | bed-sores | 3 |
100 | vres | 1 |
101 | drugs/diseases | 1 |
102 | thiolases | 1 |
103 | mannosyltransferases | 1 |
104 | tahsfs | 1 |
105 | f3hs | 2 |
106 | click-throughs | 2 |
107 | endpoints.ais | 1 |
108 | countries.this | 1 |
109 | pyelitis/pyelonephritis | 1 |
110 | pyocystitis | 1 |
111 | 2d-crystals | 1 |
112 | artiodactyls | 4 |
113 | influenza-like-symptoms | 1 |
114 | manitobans | 5 |
115 | zang-organs | 5 |
116 | cells/tissues/organs | 1 |
117 | peptides/proteins | 2 |
118 | metaproteins | 1 |
119 | amoxycillins | 1 |
120 | countries/regions | 6 |
121 | methods.conclusions | 1 |
122 | com-plications | 1 |
123 | drugs/combinations | 1 |
124 | studies/interventions | 1 |
125 | eye-tech-solutions | 1 |
126 | resons | 1 |
127 | compairsons | 1 |
128 | subgenogroups | 1 |
129 | reserachers | 1 |
130 | professionals-researchers | 1 |
131 | medicalresearchers | 1 |
132 | gold-miners | 2 |
133 | food-allergic-children/carers | 1 |
134 | yers | 1 |
135 | broncodilators | 1 |
136 | rejectors | 1 |
137 | hormones/elicitors | 1 |
138 | handcrafts | 1 |
139 | ravlts | 1 |
140 | contingents | 1 |
141 | mp29-02-patients | 1 |
142 | continents | 120 |
143 | policies/reports | 1 |
144 | embryo/foetus | 1 |
145 | minnows | 6 |
146 | amaoxs | 1 |
147 | omzs | 1 |
148 | trpv1-dependent | 1 |
149 | pol32-dependent | 1 |
150 | environmentally-persistent | 1 |
151 | minnow | 10 |
152 | 493/qaly | 1 |
153 | speleoclimatotherapy | 4 |
154 | subregistry | 1 |
155 | rehabmaster™ | 1 |